MARKET

PAHC

PAHC

Phibro Animl
NASDAQ

Real-time Quotes | Nasdaq Last Sale

22.62
-0.21
-0.92%
Closed 16:00 03/05 EST
OPEN
23.13
PREV CLOSE
22.83
HIGH
23.20
LOW
22.38
VOLUME
352.22K
TURNOVER
--
52 WEEK HIGH
28.51
52 WEEK LOW
16.27
MARKET CAP
915.06M
P/E (TTM)
20.71
1D
5D
1M
3M
1Y
5Y
Why Is Phibro (PAHC) Up 1.1% Since Last Earnings Report?
Zacks.com · 2d ago
Why Is Phibro (PAHC) Up 1.1% Since Last Earnings Report?
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · 2d ago
Immune Adjuvant Market Analysis Size, Growth, Comparison Regions, Types and Applications 2020-2027 by Ameco Research
pune, India, Wed, 03 Mar 2021 05:07:07 / Comserve Inc. / -- The "Immune Adjuvant - Market Analysis, Trends, and Forecasts" report has been added to Ameco...
Comserve · 5d ago
Immunopotentiator Market Challenges, Business Opportunities, Current Trends and Industry Analysis 2020-2027 by Ameco Research
Comserve · 5d ago
GLOBAL FEED ADDITIVES MARKET FORECAST 2021-2028
New York, March 01, Mar 01, 2021 (GLOBE NEWSWIRE via COMTEX) -- New York, March 01, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the...
GlobeNewswire · 03/01 10:49
Veterinary Anti-infectives Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027
Market Insight Reports · 02/25 12:34
Immune Adjuvant Market Segmented Application and Geography Trends, Growth and Forecasts to 2020 - 2027 By Ameco Research
pune, India, Thu, 25 Feb 2021 06:19:15 / Comserve Inc. / -- The global Immune Adjuvant market is segmented by company, region (country), by Type, and by...
Comserve · 02/25 11:20
Immunopotentiator Market Analysis, Trends and Industry Forecast to 2020- 2027 By Ameco Research
Comserve · 02/25 10:40
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PAHC. Analyze the recent business situations of Phibro Animl through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PAHC stock price target is 20.00 with a high estimate of 23.00 and a low estimate of 17.00.
EPS
Institutional Holdings
Institutions: 249
Institutional Holdings: 26.11M
% Owned: 64.54%
Shares Outstanding: 40.45M
TypeInstitutionsShares
Increased
43
1.36M
New
32
460.60K
Decreased
55
2.16M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+1.51%
Pharmaceuticals & Medical Research
+1.63%
Key Executives
Chairman/President/Chief Executive Officer/Director
Jack Bendheim
Chief Financial Officer
Damian Finio
Corporate Executive/Director
Jonathan Bendheim
Corporate Executive
Rob Aukerman
Chief Operating Officer
Larry Miller
Executive Vice President/Director
Daniel Bendheim
Senior Vice President/General Counsel/Secretary
Thomas Dagger
Senior Vice President/Director of Human Resources
Lisa Escudero
Vice President - Finance/Treasurer
Anthony Andolino
Independent Director
Gerald Carlson
Independent Director
E. Thomas Corcoran
Independent Director
Sam Gejdenson
Independent Director
Mary Malanoski
Independent Director
Carol Wrenn
Declaration Date
Dividend Per Share
Ex-Div Date
02/01/2021
Dividend USD 0.12
03/02/2021
11/02/2020
Dividend USD 0.12
11/24/2020
07/27/2020
Dividend USD 0.12
09/01/2020
05/04/2020
Dividend USD 0.12
06/02/2020
02/03/2020
Dividend USD 0.12
03/03/2020
11/04/2019
Dividend USD 0.12
11/26/2019
07/29/2019
Dividend USD 0.12
09/03/2019
05/06/2019
Dividend USD 0.12
06/04/2019
02/06/2019
Dividend USD 0.12
03/05/2019
11/05/2018
Dividend USD 0.12
11/27/2018
07/30/2018
Dividend USD 0.1
09/04/2018
05/07/2018
Dividend USD 0.1
06/05/2018
02/05/2018
Dividend USD 0.1
03/06/2018
11/06/2017
Dividend USD 0.1
12/05/2017
07/24/2017
Dividend USD 0.1
09/01/2017
05/08/2017
Dividend USD 0.1
05/26/2017
02/06/2017
Dividend USD 0.1
02/27/2017
11/07/2016
Dividend USD 0.1
11/28/2016
07/25/2016
Dividend USD 0.1
09/02/2016
05/09/2016
Dividend USD 0.1
05/27/2016
02/08/2016
Dividend USD 0.1
02/29/2016
11/09/2015
Dividend USD 0.1
11/30/2015
07/27/2015
Dividend USD 0.1
08/31/2015
05/11/2015
Dividend USD 0.1
06/01/2015
02/09/2015
Dividend USD 0.1
03/02/2015
11/10/2014
Dividend USD 0.1
12/01/2014
07/28/2014
Dividend USD 0.1
08/29/2014
About PAHC
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products. The Company also manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. The Company's Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.

Webull offers kinds of Phibro Animal Health Corp stock information, including NASDAQ:PAHC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PAHC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PAHC stock methods without spending real money on the virtual paper trading platform.